Skip to main content
Premium Trial:

Request an Annual Quote

Women's Health Startup Adyn Raises $2.5M in Seed Funding

NEW YORK — Women's health startup Adyn said on Monday that it has raised $2.5 million in seed funding to help advance its birth control selection test.

The round was led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, and Ascend VC, as well as individual investors Anne Wojcicki of 23andMe, Nish Bhat of Color Genomics, Qasar Younis of Applied Intuition, and Ashley Mayer of Glossier.

Adyn said that the funds will help it commercialize its Birth Control Optimization Test, which uses saliva and finger prick blood samples collected at home to determine a woman's hormone levels and genetic risk of birth control-associated blood clots and depression. These data are integrated with the user's medical history and side effect profiles of estrogens and progestins used in hormonal contraception to make birth control recommendations.

Seattle-based Adyn said it has opened a waitlist for the test, which is expected to ship before the end of the year.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.